You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
Rivaroxaban-d4 is a novel labeled antithrombotic agent. A highly potent and selective, direct FXa inhibitor.
Ansell, J., et al.: Drugs, 64, 1 (2004) Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005) Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005)
See how others have used Rivaroxaban-d4. Click on the entry to view the PubMed entry .
PMID: # 29972633 Bashir, B.|Stickle, DF.|Chervoneva, I.|Kraft, WK.| et al. 2018. Clin Transl Sci. 11: 590-596.
PMID: # 28170419 Derogis, PB.|Sanches, LR.|de Aranda, VF.|Colombini, MP.|Mangueira, CL.|Katz, M.|Faulhaber, AC.|Mendes, CE.|Ferreira, CE.|França, CN.|Guerra, JC.| et al. 2017. PLoS ONE. 12: e0171272.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.